YAP1 and diabetic kidney disease: Particularly, at the post-translation level, our findings unmasked the activation of the Hippo signaling pathway in tubule cells affected by DKD, thus leading to a significantly decreased accumulation of the key downstream mediator YAP1 in the nucleus where it typically binds to TEA domain transcription factors and drives the expression of target genes (Fig. 2J).